FMP
Virtus LifeSci Biotech Products ETF
BBP
AMEX
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
61.12 USD
0.3895 (0.637%)
Valuation Date:
Jan 3, 2025 11:55 AM
Share Price on Valuation Date
$61.12
Stock Beta
0.68
Shares Outstanding
382589